ABT · Abbott Laboratories
$111.25
-0.02 (-0.02%)
At close · Aug 14
Market Cap
$194.07B
Shares
1.74B
Abbott Laboratories Earnings Call Transcripts
Every quarterly earnings call for Abbott Laboratories (ABT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼4.7%
$10.41B
$1.44B
'22 Q3
22-10-19
▼12%
$10.09B
$1.03B
'22 Q4
23-01-25
▼18.1%
$9.75B
$1.32B
'23 Q1
23-04-19
▼11.4%
$9.98B
$1.38B
'23 Q2
23-07-20
▼2.6%
$10.14B
$1.44B
'23 Q3
23-10-18
▲1.5%
$10.24B
$1.59B
'23 Q4
24-01-24
▲2.2%
$9.96B
$1.23B
'24 Q1
24-04-17
▲4%
$10.38B
$1.30B
'24 Q2
24-07-18
▲4.9%
$10.63B
$1.65B
'24 Q3
24-10-16
▲7.2%
$10.97B
$9.23B
'24 Q4
25-01-22
▲4%
$10.36B
$1.32B
'25 Q1
25-04-16
▲7.4%
$11.14B
$1.78B
'25 Q2
25-07-17
▲6.9%
$11.37B
$1.64B
'25 Q3
25-10-15
▲4.4%
$11.46B
$1.78B
'25 Q4
26-01-22
LATEST
▲7.8%
$11.16B
$1.08B
'26 Q1
26-04-16
Earnings call
FY26 · Q2
2026-07-16
Abbott Laboratories Q2 FY2026 Earnings Call
Confident tone
Guidance and EPS Outlook
Diagnostics
Medical Devices / Electrophysiology
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-16
Abbott Laboratories Q1 FY2026 Earnings Call
Positive tone
Exact Sciences acquisition
China VBP headwinds
Diagnostics / Core Lab
Revenue
$11.16B
▲ 7.8% YoY Diluted EPS
$0.61
▼ 19.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-22
Abbott Laboratories Q4 FY2025 Earnings Call
Positive tone
Nutrition recovery and volume transition
Medical devices growth and innovation
2026 guidance and tariff exposure
Revenue
$11.46B*
▲ 4.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-15
Abbott Laboratories Q3 FY2025 Earnings Call
Confident tone
China Diagnostics Headwinds
New Product Launches
Structural Heart Portfolio
Revenue
$11.37B
▲ 6.9% YoY Diluted EPS
$0.94
▲ 0% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-17
Abbott Laboratories Q2 FY2025 Earnings Call
Confident tone
M&A Opportunities
Medical Devices Growth
Diabetes Care / Libre
Revenue
$11.14B
▲ 7.4% YoY Diluted EPS
$1.01
▲ 36.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-16
Abbott Laboratories Q1 FY2025 Earnings Call
Positive tone
Tariffs and mitigation
Electrophysiology and structural heart
Diversified business model and execution
Revenue
$10.36B
▲ 4% YoY Diluted EPS
$0.76
▲ 8.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-22
Abbott Laboratories Q4 FY2024 Earnings Call
Confident tone
Quarterly and Full-Year Financial Performance
2025 Guidance and Outlook
Medical Devices / MedTech Portfolio
Revenue
$10.97B*
▲ 7.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-16
Abbott Laboratories Q3 FY2024 Earnings Call
Confident tone
Diabetes Care / FreeStyle Libre
Gross Margin Expansion
Electrophysiology Pipeline
Revenue
$10.63B
▲ 4.9% YoY Diluted EPS
$0.94
▲ 14.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-18
Abbott Laboratories Q2 FY2024 Earnings Call
Confident tone
Structural heart / Amulet
Established Pharmaceuticals and biosimilars
Nutrition (including NEC litigation)
Revenue
$10.38B
▲ 4% YoY Diluted EPS
$0.74
▼ 5.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-17
Abbott Laboratories Q1 FY2024 Earnings Call
Confident tone
Pipeline and Product Approvals
Structural Heart Portfolio
Nutrition Business
Revenue
$9.96B
▲ 2.2% YoY Diluted EPS
$0.70
▼ 6.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-24
Abbott Laboratories Q4 FY2023 Earnings Call
Confident tone
COVID Testing Wind-Down and Base Business Strength
R&D Pipeline and Product Approvals
2024 Guidance and Outlook
Revenue
$10.24B*
▲ 1.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-18
Abbott Laboratories Q3 FY2023 Earnings Call
Revenue
$10.14B
▼ 2.6% YoY Diluted EPS
$0.82
▲ 1.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-20
Abbott Laboratories Q2 FY2023 Earnings Call
Revenue
$9.98B
▼ 11.4% YoY Diluted EPS
$0.78
▼ 31.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-19
Abbott Laboratories Q1 FY2023 Earnings Call
Revenue
$9.75B
▼ 18.1% YoY Diluted EPS
$0.75
▼ 45.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-25
Abbott Laboratories Q4 FY2022 Earnings Call
Revenue
$10.09B*
▼ 12% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-19
Abbott Laboratories Q3 FY2022 Earnings Call
Revenue
$10.41B
▼ 4.7% YoY Diluted EPS
$0.81
▼ 30.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-20
Abbott Laboratories Q2 FY2022 Earnings Call
Revenue
$11.26B
▲ 10.1% YoY Diluted EPS
$1.14
▲ 72.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-20
Abbott Laboratories Q1 FY2022 Earnings Call
Revenue
$11.89B
▲ 13.8% YoY Diluted EPS
$1.37
▲ 37% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Abbott Laboratories Q4 FY2021 Earnings Call
Revenue
$11.47B*
▲ 7.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-20
Abbott Laboratories Q3 FY2021 Earnings Call
Revenue
$10.93B
▲ 23.4% YoY Diluted EPS
$1.17
▲ 69.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-22
Abbott Laboratories Q2 FY2021 Earnings Call
Revenue
$10.22B
▲ 39.5% YoY Diluted EPS
$0.66
▲ 120% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-20
Abbott Laboratories Q1 FY2021 Earnings Call
Revenue
$10.46B
▲ 35.3% YoY Diluted EPS
$1.00
▲ 222.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
Abbott Laboratories Q4 FY2020 Earnings Call
Revenue
$10.70B*
▲ 28.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-21
Abbott Laboratories Q3 FY2020 Earnings Call
Revenue
$8.85B
▲ 9.6% YoY Diluted EPS
$0.69
▲ 30.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-16
Abbott Laboratories Q2 FY2020 Earnings Call
Revenue
$7.33B
▼ 8.2% YoY Diluted EPS
$0.30
▼ 46.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
Abbott Laboratories Q1 FY2020 Earnings Call
Revenue
$7.73B
▲ 2.5% YoY Diluted EPS
$0.31
▼ 18.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-22
Abbott Laboratories Q4 FY2019 Earnings Call
Revenue
$8.31B
▲ 7.1% YoY Diluted EPS
$0.59
▲ 59.5% YoY Gross margin
52.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls